Rex Capital Advisors Exits Position in Halyard Health Inc (HYH)

Halyard Health Inc (HYH) : Rex Capital Advisors has sold out all of its stake in Halyard Health Inc during the most recent quarter, according to the disclosure filed by the company on May 13, 2016 with the SEC. The investment management company has sold out 6,945 shares of Halyard Health Inc which is valued at $194,946.

Other Hedge Funds, Including , Cannell Peter B Co Inc reduced its stake in HYH by selling 2,500 shares or 12.79% in the most recent quarter. The Hedge Fund company now holds 17,045 shares of HYH which is valued at $478,453. Halyard Health Inc makes up approx 0.02% of Cannell Peter B Co Inc’s portfolio. Huntington Asset Advisors sold out all of its stake in HYH during the most recent quarter. The investment firm sold 12 shares of HYH which is valued $337.Cornerstone Capital Management Holdings. reduced its stake in HYH by selling 8,700 shares or 20.0% in the most recent quarter. The Hedge Fund company now holds 34,800 shares of HYH which is valued at $976,836. Halyard Health Inc makes up approx 0.01% of Cornerstone Capital Management Holdings.’s portfolio.Municipal Employees’ Retirement System Of Michigan boosted its stake in HYH in the latest quarter, The investment management firm added 630 additional shares and now holds a total of 15,540 shares of Halyard Health Inc which is valued at $455,477. Halyard Health Inc makes up approx 0.03% of Municipal Employees’ Retirement System Of Michigan’s portfolio.

Halyard Health Inc opened for trading at $30.09 and hit $30.5 on the upside on Wednesday, eventually ending the session at $30.15, with a gain of 0.47% or 0.14 points. The heightened volatility saw the trading volume jump to 2,92,863 shares. Company has a market cap of $1,407 M.

On the company’s financial health, Halyard Health Inc reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.19 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.34. The company had revenue of $385.00 million for the quarter, compared to analysts expectations of $370.54 million. The company’s revenue was down -2.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.51 EPS.

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Leave a Reply

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.